---
$id: https://graph.org.ai/products/commodity/51361915
$type: Product
source: UNSPSC
code: "51361915"
title: "Metharbital"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metharbital

**UNSPSC Code**: 51361915
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C9H14N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 02OS7K758T, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5,5-diethyl-1-methyl- but generally known as metharbital, which bears US NIH Compound Identifier 4099. European Medicines Agency schedules Metharbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08841MIG. The term METHARBITAL is an International Non-Proprietary Name. World Health Organization schedules metharbital in its Anatomical Therapeutic Chemical (ATC) Classification. METHARBITAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metharbital under HS 29335400 and SITC kg. As of Q4 2014, METHARBITAL remains the US FDA Preferred Term for this commodity. Metharbital bears US NLM identifiers UMLS ID C0025629 and NCI Concept Code C66113. SMILES: O=C1N(C(=O)NC(=O)C1(CC)CC)C.

